Comments
Clinigene International, a subsidiary of Biocon Ltd, has entered into a partnership with US-based Spaulding Clinical Research for providing comprehensive early clinical solutions to pharmaceutical and biotech clients.
According to Dr Abhijit Barve, Chief Operating Officer, Clinigene, the partnership establishes a reliable, trustworthy and cost-efficient global footprint for clinical pharmacology services providing an opportunity for both the organisations to engage pharmaceutical clients strategically and accelerate first-in-human to proof-of-concept clinical development.
Spaulding Clinical Research has expertise on clinical pharmacology, cardiac core lab and medical device manufacture. It also operates a 105-bed clinical pharmacology unit with 96-beds of Mortara telemetry in West Bend, Wisconsin.
“Pharmaceutical clients globally are increasingly seeking strategies to expedite their early clinical development, streamlining processes while maintaining high quality. Our strategic partnership is designed to deliver this in a very cost-effective manner,” Dr Barve said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.